Brett Froeliger to Middle Aged
This is a "connection" page, showing publications Brett Froeliger has written about Middle Aged.
Connection Strength
0.563
-
Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Sci Adv. 2019 10; 5(10):eaax1569.
Score: 0.048
-
Impaired frontostriatal functional connectivity among chronic opioid using pain patients is associated with dysregulated affect. Addict Biol. 2020 03; 25(2):e12743.
Score: 0.046
-
Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse. J Addict Dis. 2018 Jan-Jun; 37(1-2):14-22.
Score: 0.043
-
Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the cue-primed reactivity task. Drug Alcohol Depend. 2018 06 01; 187:13-21.
Score: 0.043
-
Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability. JAMA Psychiatry. 2017 04 01; 74(4):379-386.
Score: 0.040
-
Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards. Psychother Psychosom. 2017; 86(2):111-112.
Score: 0.039
-
The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242.
Score: 0.036
-
Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition. Psychiatry Res. 2013 Jan 30; 211(1):57-63.
Score: 0.029
-
Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. Psychopharmacology (Berl). 2009 Sep; 205(4):625-33.
Score: 0.023
-
Serotonin transporter genotype and depressive symptoms moderate effects of nicotine on spatial working memory. Exp Clin Psychopharmacol. 2009 Jun; 17(3):173-80.
Score: 0.023
-
Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial. JAMA Intern Med. 2022 04 01; 182(4):407-417.
Score: 0.014
-
The temporal dynamics of emotion dysregulation in prescription opioid misuse. Prog Neuropsychopharmacol Biol Psychiatry. 2021 01 10; 104:110024.
Score: 0.012
-
Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial. J Consult Clin Psychol. 2019 Oct; 87(10):927-940.
Score: 0.012
-
Effects of Mindfulness-Oriented Recovery Enhancement Versus Social Support on Negative Affective Interference During Inhibitory Control Among Opioid-Treated Chronic Pain Patients: A Pilot Mechanistic Study. Ann Behav Med. 2019 08 29; 53(10):865-876.
Score: 0.012
-
Multi-method assessment of distress tolerance and smoking-related factors among adult daily smokers. Exp Clin Psychopharmacol. 2019 Apr; 27(2):136-145.
Score: 0.011
-
A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
Score: 0.010
-
Effect of a Brief Memory Updating Intervention on Smoking Behavior: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Mar 01; 74(3):214-223.
Score: 0.010
-
Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse. Psychopharmacology (Berl). 2017 Feb; 234(4):621-629.
Score: 0.010
-
A Pilot Randomized Crossover Trial of Electronic Cigarette Sampling Among Smokers. Nicotine Tob Res. 2017 Feb; 19(2):176-182.
Score: 0.010
-
The effects of nicotine and non-nicotine smoking factors on working memory and associated brain function. Addict Biol. 2016 07; 21(4):954-61.
Score: 0.009
-
Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation Outcomes. Neuropsychopharmacology. 2015 Oct; 40(11):2648-56.
Score: 0.009
-
Allostatic dysregulation of natural reward processing in prescription opioid misuse: autonomic and attentional evidence. Biol Psychol. 2015 Feb; 105:124-9.
Score: 0.009
-
Neural biomarkers for assessing different types of imagery in pictorial health warning labels for cigarette packaging: a cross-sectional study. BMJ Open. 2014 Dec 31; 4(12):e006411.
Score: 0.009
-
Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT. J Behav Med. 2015 Apr; 38(2):327-36.
Score: 0.008
-
Smoking automaticity and tolerance moderate brain activation during explore-exploit behavior. Psychiatry Res. 2014 Dec 30; 224(3):254-61.
Score: 0.008
-
An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
Score: 0.008
-
Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling. Neuropsychopharmacology. 2014 Nov; 39(12):2750-9.
Score: 0.008
-
Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity. Psychopharmacology (Berl). 2014 Aug; 231(16):3229-38.
Score: 0.008
-
Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. J Consult Clin Psychol. 2014 Jun; 82(3):448-459.
Score: 0.008
-
Attentional bias for prescription opioid cues among opioid dependent chronic pain patients. J Behav Med. 2013 Dec; 36(6):611-20.
Score: 0.007